Table 3.
Summary of main critical properties for natural mucus wound dressing and their advantages and limitations
| Crucial properties | Definition & clinical importance | Advantages & limitations | ||
|---|---|---|---|---|
| Animal mucus | Plant mucilage | Complex-sourced natural mucus | ||
| Wet adhesion and absorption capacity | Adhere to moist wound bed, absorb exudate, maintain optimal hydration and prevent maceration | Hydrophobic molecules enable direct tissue adhesion in high-exudate environment; Sensitive to temperature/pH fluctuations | High absorption of polysaccharides facilitates wet adhesion and water retention; Excessive swelling weakens adhesion; Reduced adhesion to dry and necrotic tissues | Nanofiber-wound interlock; Crosslinking reduces capacity; Require modification for enhanced adhesion |
| Moisture retention and oxygen permeability | Maintain hydration for autolytic debridement and cell migration, enable oxygen exchange for aerobic healing and angiogenesis | Moderate absorption for protein and lipid; Susceptible to enzymatic degradation; Long-term retention may cause collapse; High-protein exudate clogs pores | Hydrophilic matrix sustains moisture and oxygen exchange; Over-hydration risk in high-exudate environment; Reduced water retention during degradation | Elevated concentration induces hypoxia; Unsuitable for anaerobic infection control; Synthetic additives impede gas exchange and breakdown |
| Mechanical resilience | Resists deformation and fracture during movement | Require prolonged in situ gelation time; Relatively low strength tears during movement; Shrink upon drying, pulling wound edges | Excellent contour adaptation; High ductility when hydrated but weak tensile strength; Brittle when dehydrated | Rigid structure limits deformation |
| Antimicrobial activity | Inherent capacity to kill/inhibit pathogens or incorporate antimicrobial agents | Defensin and immunoglobulins provide activity; Reduced by proteases in chronic wounds | Anthraquinones and acemannan disrupt biofilms; Limited efficacy against Gram-negative strains | Species-dependent |
| Immunomodulation | Modulates inflammatory cytokines to prevent chronic inflammation | Risk of allergy and immune reactions from exogenous factors | Effects may be inconsistent or paradoxical at high concentrations | Potential endotoxin contamination |
| Biocompatibility | Non-toxic, non-irritating, non-bioaccumulative, and non-allergenic to surrounding tissue | Zoonotic pathogen transmission risk; Potential allergens | Generally low immunogenicity; Residual pesticides and extraction solvents may cause reactions | Context-dependent |
| Ease of application and removal | Applicable and removable without causing pain or tissue damage | Require temperature control; Residue risk from fragments; | Brittle films may fragment during removal; potential residue | Without concentration processing; Complex applications require professional handling |
| Production feasibility | Sustainable source, cost-effectiveness, scalability, sterilization compatibility, regulatory pathway | High-cost live harvesting; Expensive medical-grade purification; Sterilization and storage escalate expenses | Renewable farming sources; Seasonal batch variability impedes standardization | Require equipment investment; Rigorous filtration needed for particulate residues |
| Other considerations | Odor control, pain management, eco-friendliness | Sulfur and amine components yield distinctive odors; Neuroinflammatory reaction risk | Cooling sensation reduces burning; Peculiar odor when improperly preserved | Degradation often requires multiple enzymes; Added complexity affects degradation |